Displaying items by tag: women

You may be eligible to participate in a research study about the effects of sacubitril/valsartan on how your body handles insulin and glucose. This medication is related to the heart. Eligible participants must be healthy men and women, African American, and have no history of diabetes, heart problems, or kidney problems. The study involves performing some exercise, taking sacubitril/valsartan, and collecting blood samples. Participants will be compensated. Please e-mail Nehal Vekariya at nvekariya@uabmc.edu if you are interested.
Published in Clinical Trials
UAB's Urogynecology and Pelvic Reconstructive Surgery is conducting a 3 month at-home non-invasive lower leg stimulation study. You may be eligible if you are female and 18 years of age and older, have a history of chronic Bowel Leakage for at least 6 months, and have tried at least 2 treatments, including medications, diet, and pelvic exercises. Compensation will be provided. If you would like more information about the study, please contact 205-934-5498.
Published in Clinical Trials
Are you taking Metformin alone or metformin with a sodium-glucose transport protein 2 (SGLT2) inhibitor to treat your diabetes? The University of Alabama at Birmingham, Department of Nutrition Sciences, is conducting a 39-week research study to see how two new study medicines work together on blood sugar levels in people with Type 2 diabetes. Qualified participants will receive study-drug free of charge and may be compensated for time and travel. For more information, and to check your eligibility to join, please contact (205) 996-4015 or email at ccnrn@uab.edu.
Published in Clinical Trials
You may be eligible for a research study if you are a female 18 or older and have been diagnosed with endometriosis. Study medication and clinic visits provided at no cost. Compensation provided for every visit. Please call 205-934-1322 or email slangan@uabmc.edu to hear more information.
Published in Clinical Trials
The purpose of the study is to measure maximum walking speed and step length with virtual reality and customizable exercise games as feedback sources on a robotic treadmill. The targeted population is individuals with hemiparesis, in a chronic and stable stroke stage, who are able to follow instructions, and able to walk independently for at least three minutes. Based on a phone screening, eligible participants will attend up to two separate sessions at UAB Spain Rehabilitation Center. In each session, they will go into different walking or stepping performance conditions. The session will last about two hours, and participants will be paid 30$ per session for their time and effort. For more information please call Saleh Alhirsan at (205) 261-3853 or by email atalhirsan@uab.edu.
Published in Clinical Trials
We are looking for adults between 21-55 years old and diagnosed with Attention Deficit and Hyperactivity Disorder (ADHD), and use stimulant medication to participate in our study. We want to determine the role of ADHD stimulant medication on balance and other factors, such as physical activity in improving balance performance. We hypothesize that ADHD will improve balance performance in adults with ADHD. We also hypothesize that moderate to vigorous physical activity behaviors will positively influence balance performance in this population. Participants will be required to make two visits. Once on-medication; and on the second visit, we will ask participants to forgo ADHD medication 24 hours before the testing. For more information please contact Mansour at (205) 503-2977, or by email at amansour@uab.edu.
Published in Clinical Trials
The purpose of the SCIPE study is to examine two 8-week remotely delivered exercise interventions: Movement-to-Music, and Standard Exercise Training. Enrolled participants will be randomized into one of three groups: M2M, SET, or attention control. The primary goal of this study is to examine changes in physical activity levels after the 8-week M2M and SET interventions. We hypothesize that M2M and SET participants will have significant increases in physical activity, sleep quality, quality of life, and decreases in pain compared to the Attention Control group after the 8-week intervention. The secondary aim is to examine the effects of the M2M and SET interventions on health and quality of life outcomes. Exercise enjoyment in M2M and SET participants will also be explored. The tertiary aim is to evaluate the demographic, clinical, and psychosocial variables of two participant groups: 1) compliant participants who completed ≥ 50% of the intervention, and 2) non-compliant participants who completed post-testing but only 50% of the intervention, or did not complete post-testing. The SCIPE study will take place entirely online. The exercise program will be delivered to you in a video format, so you can exercise anywhere that is convenient for you. For more information please contact (205) 209-2245 or email scipe@uab.edu.
Published in Clinical Trials
Then you may be eligible for a research study. If you are female ages 18-49 and were diagnosed with endometriosis in the last 10 years, you may qualify to receive study medication at no cost to you. For more information call 205-934-1322 or email slangan@uabmc.edu. Compensation provided for completed visits.
Published in Clinical Trials
If you are 18 years of age or older and currently taking the blood thinners Xarelto (rivaroxaban) or Eliquis (apixaban), you may be eligible to participate in a research study. This study is being done to determine how your kidney function affects how you metabolize Xarelto or Eliquis. The study involves keeping a medication log for one week and one (12 hour) visit to UAB where we will collect blood samples at different times during the day. Participants will be compensated $150 for completing the one-day study visit. If you are interested or for more information, please contact our research team at pkpdstudy@uabmc.eduor 205-917-9800.
Published in Clinical Trials
You may be eligible to participate in a research study about the effects of Sacubitril/Valsartan on how your body handles insulin and glucose. This medication is related to the heart. Eligible participants must be healthy men and women, African American, and have no history of diabetes, heart problems, or kidney problems. The study involves exercising, taking sacubitril/valsartan or valsartan, and collecting blood samples. Participants will be compensated. Please e-mail Dr. Vibhu Parcha, vparcha@uabmc.edu if you are interested. 
Published in Clinical Trials
You may be eligible to participate in a research study about the effects of exercise and Metoprolol, a blood pressure pill, on a protein in your blood. This protein is related to heart disease. Eligible participants must be healthy men and women, African American or Caucasian with no history of diabetes, heart problems, or kidney problems. The study involves exercising, taking metoprolol, consuming prepared meals, and collecting blood samples. Participants will be compensated. Please email Dr. Vibhu Parcha at vparcha@uabmc.edu if you are interested.
Published in Clinical Trials

The RECOVER study will investigate the use of Vagus Nerve Stimulation (VNS) Therapy in up to 1,000 people across the United States. To join the RECOVER study you must be 18 years or older and: currently depressed, have bi-polar depression that has lasted for at least two years or recurred several times, and have tried at least four types of antidepressant treatments and not found them helpful. Please leave a voice message at (205) 975-0068 or email candacegreen@uabmc.edu for more information.

Published in Clinical Trials
If you are at least 18 years of age, can read and write in English, are generally healthy, and have no history of mental illness or psychiatric disorders, please leave a voice message at (205) 934-2484 or email lalexander@uabmc.edu for more information.
Published in Clinical Trials
You may be able to participate in this study if you: are 18 years of age or older, have been diagnosed with major depressive disorder, MDD, and have not adequately responded to at least 2 different antidepressant treatments. Please leave a voice message at (205) 934-2484 or email lalexander@uabmc.edu for more information.
Published in Clinical Trials
If you have Major Depressive Disorder (MDD) that hasn’t responded to anti-depressant medication, learn about this research study of an investigational drug for MDD. As part of their study participation, patients will be regularly evaluated and closely monitored by a team of medical professionals. To pre-qualify for this study, you must: be 18 to 65 years of age; have been diagnosed with MDD; be in a current depressive episode for at least 8 weeks but not more than 12 months; and have been taking an antidepressant medication for at least the last 8 weeks. Additional criteria will apply. All study-related visits, tests, and study drugs will be provided at no cost. In addition, reimbursement for study-related travel may be provided. Please leave a voice message at (205) 934-2484 or email lalexander@uabmc.edu for more information.
Published in Clinical Trials
If you have major depressive disorder (MDD) and are in a current depressive episode, we invite you to learn about a research study of an investigational drug that is taken with your current antidepressant medication. In this study, researchers will evaluate the safety and efficacy of the investigational drug as an add-on therapy to your current antidepressant medication. To prequalify for this study you must be 18 to 65 years of age, have been diagnosed with recurrent MDD, be in a current major depressive episode for at least the last 8 weeks, and not experiencing a satisfactory improvement in your symptoms of depression with your current treatment. All study-related visits, tests, and drugs will be provided at no cost. In addition, reimbursement for study-related travel may be provided. Please leave a voice message at (205) 934-2484 or email lalexander@uabmc.edu for more information.
Published in Clinical Trials
This is a paid research opportunity for adults who provide care for adult loved ones 45 years or older. We are actively recruiting for a research study to examine caregivers’ experiences and health outcomes. To be eligible, caregiver participants need to commit to providing care for their loved ones at least five hours weekly, and their loved ones need to be ages 45 and older. The study takes approximately 45 minutes to complete and can be completed via our online survey or over the phone with one of our trained research assistants. Participants will receive a $20 gift card for completing the study. The link to complete the study is: https://uab.co1.qualtrics.com/jfe/form/SV_bmAfy0dohaFEciG. For more information, please call and leave a voicemail for our research lab at (205) 975-9452, or email Wesley Browning at wbro9119@uab.edu, or Celine Atkins at gcat347@uab.edu.
Published in Clinical Trials
The University of Alabama at Birmingham, Department of Nutrition Sciences, is conducting a research study to evaluate the effectiveness of an investigational drug to treat people with Type 2 Diabetes and obesity. To qualify, you must have Type 2 Diabetes, older than 18 years old, moderately overweight, diet-controlled or taking oral diabetes medications. Qualified participants will receive the study drug free of charge and compensation for time and travel. For more information, and to see if you might be eligible to join, please contact (205) 996-4015 or email at ccnrn@uab.edu.
Published in Clinical Trials
Looking for individuals between the ages of 18-70 with a diagnosis of traumatic brain injury, spinal cord injury, spina bifida, cerebral palsy, stroke, Parkinson disease, or multiple sclerosis to participate in Movement-to-Music (M2M), a rhythmic-based exercise program provided entirely remotely from Lakeshore Foundation. You may be eligible if you have stable cardiovascular conditions and have not participated in a similar research study in the past 6 months. All equipment for completing the program and additional compensation provided. To learn more about this opportunity and if you are eligible, please call Lori Theriot at (205) 313-7455 or email m2mstudy@uab.edu.
Published in Clinical Trials
We are looking for adults with type 2 diabetes for a research study to see if eating large amounts of whole fruit can improve your blood sugar and reduce your need for diabetes medications. You may be eligible if you are 20-65 years old, overweight (BMI 27-45), diagnosed with type 2 diabetes within the last 6 years, and are not taking insulin. Participants will be provided with meals for 12 weeks, a high-speed Vita-Mix blender, and $1,375 for completing the study. Since this study is time-intensive, we are seeking only highly motivated and dedicated participants. If you are interested, please complete the brief electronic form at http://bit.ly/fruit_study. For more information, please contact Cody Hanick at chanick@uab.edu or (262) 923-0672.
Published in Clinical Trials

We are looking for adults with type 2 diabetes for an exciting research study to see whether intermittent fasting and/or using light therapy can improve your blood sugar, improve your overall health, and reset your body clock. Participants will either eat early in the day, graze throughout the day, and/or use a special light therapy box or glasses. You may be eligible if you have type 2 diabetes, are 30-80 years old, are not taking insulin, and usually wake up between 5:00 and 9:00 am. The main part of the study lasts 16 weeks and involves two overnight tests in our clinic (which can be done on weekends, if preferred). Participants will receive $2400 for completing the study.

If you are interested, please follow the link http://bit.ly/clocksstudy to apply for the CLOCKS study. Or for more information, please contact our research team for more information at CLOCKSSTUDY@uab.edu or 205-484-7329 or 205-484-5633.

Published in Clinical Trials

We are looking for adults for an exciting research study to see whether meal timing can improve your blood sugar and your overall health. Participants will be randomly selected to either graze throughout the day, skip breakfast, or skip dinner for 8 weeks. You may be eligible if you are 30-70 years old, are overweight, are not taking diabetes medication, and wake up between 5:00 and 8:00 am regularly. Adults with prediabetes, blood sugar issues, or a family history of diabetes are encouraged to apply. This study involves two overnight tests in our clinic plus eating only food that we provide you. Participants will receive $1200 for completing the study and 8 weeks of meals, valued at a total of $2400. If you are interested, please visit https://bit.ly/mealtimingstudy to apply for the study. Or for more information, please contact one of our research coordinators at mealtiming@uab.edu or 205-975-3944.

Published in Clinical Trials
Is your child in good health without Diabetes, Hypertension, Hyperlipidemia, Thyroid dysfunction, Autoimmune diseases, Moderate to Severe Intellectual disability, or Taking medications affecting? If so, your child may be eligible to participate in a research study at UAB. Compensation up to $140 for two visits, each visit lasting 5 hours. For more information, please call the UAB Office of Psychiatric Research at Call: 205-975-4207
Published in Clinical Trials
Healthy men and women, ages 18 to 75, are needed for a study exploring the reason why individuals who have diabetes have an increased risk of forming a calcium oxalate kidney stone. The study involves consuming prepared meals over 4 days and collecting urine and blood. Compensation $130. Please phone Demond at 205-934- 5712 or email kidneystone@uabmc.edu, if you are interested.
Published in Clinical Trials
Adults ages 18-89 with history of kidney stones needed for a study Individuals ages 18-89 years with a history of Calcium Oxalate kidney stones, are needed for a study exploring factors that impacting oxalate metabolism in kidney stone formers. The study involves consuming prepared meals over 4 days and collecting urine and blood. Compensation up to $140. For more information, call 205-934-5712 or email kidneystone@uabmc.edu or kidneystoneresearch@uabmc.edu.
Published in Clinical Trials
Page 4 of 10